BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26928381)

  • 21. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
    Ranganathan S; Webber S; Ahuja S; Jaffe R
    Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
    Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
    J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.
    Watanabe M; Kanda J; Hishizawa M; Nishikori M; Kondo T; Yamashita K; Takaori-Kondo A
    Ann Hematol; 2020 Jul; 99(7):1565-1573. PubMed ID: 32436013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
    Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
    Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients.
    Trusson R; Serre JE; Szwarc I; Brunot V; Garrigue V; Delmas S; Kanouni T; Cartron G; Mourad G
    Transplant Proc; 2016; 48(6):1927-33. PubMed ID: 27569924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
    Fararjeh FA; Mahmood S; Tachtatzis P; Yallop D; Devereux S; Patten P; Agrawal K; Suddle A; O'Grady J; Heaton N; Marcus R; Kassam S
    Eur J Haematol; 2018 Jan; 100(1):98-103. PubMed ID: 29094407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.
    Soler MJ; Puig JM; Mir M; Parrilla J; Pedro C; Salar A; Serrano S; Lloveras J
    Transplant Proc; 2003 Aug; 35(5):1709-13. PubMed ID: 12962767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: A multicenter analysis.
    West SC; Friedland-Little JM; Schowengerdt KO; Naftel DC; Pruitt Freeze E; Smith KS; Urschel S; Michaels MG; Kirklin JK; Feingold B
    Clin Transplant; 2019 May; 33(5):e13521. PubMed ID: 30861200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
    Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.
    Trofe J; Buell JF; Beebe TM; Hanaway MJ; First MR; Alloway RR; Gross TG; Succop P; Woodle ES
    Am J Transplant; 2005 Apr; 5(4 Pt 1):775-80. PubMed ID: 15760401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
    Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
    Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial and Ethnic Disparities in the Pediatric Hodgkin Lymphoma Population.
    Grubb WR; Neboori HJ; Diaz AD; Li H; Kwon D; Panoff J
    Pediatr Blood Cancer; 2016 Mar; 63(3):428-35. PubMed ID: 26524117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
    Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
    Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary Central Nervous System Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder.
    Hori YS; Nagakita K; Ebisudani Y; Aoi M; Fukuhara T; Shinno Y
    World Neurosurg; 2018 Jun; 114():230-234. PubMed ID: 29609086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2019 Sep; 98(9):2163-2177. PubMed ID: 31243569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-transplant lymphoproliferative disease in liver transplant recipients.
    Rubio-Manzanares Dorado M; Álamo Martínez JM; Bernal Bellido C; Marín Gómez LM; Suárez Artacho G; Cepeda Franco C; Wang J; Gómez Bravo MÁ; Padillo FJ
    Rev Esp Enferm Dig; 2017 Jun; 109(6):406-413. PubMed ID: 28508661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
    Aull MJ; Buell JF; Trofe J; First MR; Alloway RR; Hanaway MJ; Wagoner L; Gross TG; Beebe T; Woodle ES
    Transplantation; 2004 Dec; 78(11):1676-82. PubMed ID: 15591959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.